The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Recognition of thalidomide defects.
Open accessAbstract
Thalidomide: a brief history Thalidomide (alpha-phthalimido-glutarimide) was developed by the German firm Chemie Grunenthal as an anticonvulsant drug.Early trials showed it to be unsuitable for this pur- pose but indicated that it had sedative proper- ties.Furthermore, it had one remarkable prop- erty: overdoses simply caused prolonged sleep, not death.The drug was first marketed in Germany in 1957 under the name Contergan, and in the UK in April 1958 as Distaval.Later, compound preparations which combined tha- lidomide with other drugs were marketed for a wide variety of indications: Asmaval for asthma, Tensival for hypertension, Valgraine for migraine, and so forth.The promotion of these products laid great stress on the safety of thalidomide, based on the remarkable property described above.German paediatricians and geneticists began to see children with gross limb malfor- mations of a most unusual pattern.When two cases were shown at a paediatric meeting in Kassel by Kosenow and Pfeiffer in October 1960, few people present had ever seen similar limb defects.Wiedemann in 1961 described 13 affected infants who had been referred to him over a period of 10 months, and noted that this amounted to an epidemic.He drew attention to a number of associated malformations in these children, including congenital heart dis- ease, microphthalmos and coloboma, intestinal atresia, renal malformations, abnormal pinnae, and facial naevus.In November 1961, Lenz suggested that these deformities resulted from the mothers having taken thalidomide.By a remarkable coincidence, the same suggestion was made at much the same time by McBride in Australia.Confirmation of this suggestion came rapidly from all parts of the British Isles, Kenya, Japan, Sweden, Belgium, Switzerland, Lebanon, Israel, Peru, Canada, Brazil, the Netherlands, and the USA.The drug had been released only for clinical trials in the USA because of concerns following reports from Europe of irreversible peripheral neur- itis as a side effect of thalidomide.Consequently there were very few cases.By con- trast, it had been on sale over the counter in Germany, and there were consequently more affected children there than anywhere else.In the UK the drug was available on prescription only, but it was used very widely for, among other problems, common symptoms of early pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A study of the German outbreak of phocomelia. The thalidomide syndrome.
Taussig, H. B. (1962) · PubMed · Cited by 184
Defects and Disabilities of Thalidomide Children
SMITHELLS, R. W. (1973) · BMJ · doi:10.1136/bmj.1.5848.269 · Cited by 114
Self-citationThe Thalidomide Syndrome: Risks of Exposure and Spectrum of Malformations
Newman, C. (1986) · Clinics in Perinatology · doi:10.1016/s0095-5108(18)30810-8 · Cited by 104
Self-citationA STUDY OF THE GERMAN OUTBREAK OF PHOCOMELIA
Taussig, H. B. (1962) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-196212000-00017 · Cited by 85
THALIDOMIDE AND MALFORMATIONS IN LIVERPOOL
SMITHELLS, R. W. (1962) · The Lancet · doi:10.1016/s0140-6736(62)92367-x · Cited by 83
Self-citationTeratogen update: Clinical aspects of thalidomide embryopathy—A continuing preoccupation
Newman, C. G. H. (1985) · Teratology · doi:10.1002/tera.1420320118 · Cited by 77
Self-citationThe effect of thalidomide intake during 113 human pregnancies
Kajii, T., Kida, M., & Takahashi, K. (1973) · Teratology · doi:10.1002/tera.1420080208 · Cited by 56
Strömland, K., Miller, M. T., & Cook, C. S. (1991) · Survey of Ophthalmology · doi:10.1016/0039-6257(91)90107-q · Cited by 51
THE INCIDENCE OF LIMB AND EAR DEFECTS SINCE THE WITHDRAWAL OF THALIDOMIDE
SMITHELLS, R. W., & Leck, I. M. (1963) · The Lancet · doi:10.1016/s0140-6736(63)92129-9 · Cited by 41
Self-citation
Cited by
Thalidomide-induced Teratogenesis: History and Mechanisms
Vargesson, N. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21096 · Cited by 912
Van Assche, G., Dignass, A., Reinisch, W., van der Woude, C. J., Sturm, A., De Vos, M., Guslandi, M., Oldenburg, B., Dotan, I., Marteau, P., et al. (2010) · Journal of Crohn's and Colitis · doi:10.1016/j.crohns.2009.09.009 · Cited by 894
Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., & Webb, C. L. (2007) · Circulation · doi:10.1161/circulationaha.106.183216 · Cited by 818
van der Woude, C. J., Ardizzone, S., Bengtson, M. B., Fiorino, G., Fraser, G., Katsanos, K., Kolacek, S., Juillerat, P., Mulders, A. G. M. G. J., Pedersen, N., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jju006 · Cited by 475
Caprilli, R., Gassull, M. A., Escher, J. C., Moser, G., Munkholm, P., Forbes, A., Hommes, D. W., Lochs, H., Angelucci, E., Cocco, A., et al. (2006) · Gut · doi:10.1136/gut.2005.081950c · Cited by 428
Metadata
- Authors
- Smithells, R. W., & Newman, C. G.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 1992-10
- Volume
- 29
- Issue
- 10
- Pages
- 716-723
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2163445917
- Cited by
- 271
- References
- 9
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.